Text Size

Cognitive Behavioral Therapy, Self-Efficacy, and Depression in Persons With Chronic Pain

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
Virginia Nash, Mayo Clinic
ClinicalTrials.gov Identifier:
NCT01055665
First received: January 21, 2010
Last updated: May 1, 2012
Last verified: May 2012
History of Changes
  Purpose

The investigators are exploring the role of Cognitive Behavioral Therapy (CBT), a treatment for depression, on self-efficacy (feeling empowered to accomplish a given task) and depression in persons with chronic pain and depression. Past research has shown that persons with chronic pain show improvement in self-efficacy and depression scores when they are using CBT. The Pain rehabilitation Center (PRC) at Mayo Clinic is adding CBT focused groups to better understand the role of CBT on self-efficacy and depression in persons with chronic pain and depression.


Condition Intervention
Depression
 Other: cognitive behavior therapy

Study Type: Observational
Study Design: Time Perspective: Retrospective
Official Title: Cognitive Behavioral Therapy, Self-Efficacy, and Depression in Persons With Chronic Pain

Resource links provided by NLM:

U.S. FDA Resources

Further study details as provided by Mayo Clinic:

Primary Outcome Measures:
  • Change on a depression and self-efficacy scale [ Time Frame: 3 weeks ] [ Designated as safety issue: No ]

Enrollment: 138
Study Start Date: October 2009
Study Completion Date: June 2010
Primary Completion Date: June 2010 (Final data collection date for primary outcome measure)
Intervention Details:
    Other: cognitive behavior therapy
    6 cognitive behavior therapy groups
Detailed Description:

Subjects will need to complete two questionnaires on admission and on discharge from the PRC program to measure self-efficacy and depression. The first is the Pain Self-Efficacy Scale (PSEQ) which is a measure of self-efficacy in persons with chronic pain. The second questionnaire is the Center for Epidemiologic Studies Depression Scale (CES-D) which is a measure of depressive symptoms in persons with chronic pain. Both scales will also be used for clinical information. Persons who score 27 or higher on the CES-D will be approached for potential consent to this evidence based project. Each patient in the PRC will participate in up to 6 CBT sessions but only persons who, upon admission, score 27 or greater on the CES-D will be studied for any changes in scores from admission to discharge.

  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population

Persons with chronic pain and depressive symptoms in a pain rehabilitation program.

Criteria

Inclusion Criteria:

  • 18 and over with chronic pain and
  • score of 27 or higher on CES-D scale

Exclusion Criteria:

  • 17 or younger, no chronic pain,
  • cognitively unable to participate in programming
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT01055665

Sponsors and Collaborators
Mayo Clinic
Investigators
Principal Investigator: Virginia R Nash, RN, MS, CNS Mayo Clinic
  More Information

No publications provided

Responsible Party: Virginia Nash, RN, Clinical Nurse Specialist, Mayo Clinic
ClinicalTrials.gov Identifier: NCT01055665     History of Changes
Other Study ID Numbers: 09-003969
Study First Received: January 21, 2010
Last Updated: May 1, 2012
Health Authority: United States: Institutional Review Board

Additional relevant MeSH terms:
Depression
Depressive Disorder
Behavioral Symptoms
Mood Disorders
Mental Disorders

ClinicalTrials.gov processed this record on May 21, 2013